Document is current
Any future updates will be listed below
-
Authors
Nawano, Takaaki
Nishida, Hayato https://orcid.org/0000-0002-8045-551X
Ichikawa, Kazunobu
Takehara, Tomohiro
Takai, Satoshi
Fukuhara, Hiroki
Matsuura, Tomohiko
Maita, Shinya
Saito, Mitsuru
Murakami, Reiichi
Hatakeyama, Shingo
Obara, Wataru
Ohyama, Chikara
Habuchi, Tomonori
Watanabe, Masafumi
Tsuchiya, Norihiko
- License Information
-
More Information
Article History
Received: 29 January 2025
Accepted: 17 September 2025
First Online: 25 September 2025
Declarations
:
: SH has received lecture fees from Ono Pharmaceutical, Bristol Myers Squibb, Janssen Pharmaceutical, MSD, and Astellas Pharma Inc. and funding for endowed chairs from Nipro Corporation and Kaneka Corporation. TH has received lecture fees from Astellas Pharma Inc., Novartis Pharmaceuticals, and Chugai Pharmaceuticals.
: All procedures involving human participants were performed in accordance with the ethical standards of the Iwate Medical University at which the studies were conducted (IRB approval number MH2019-162) and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. The study was conducted in accordance with the principles of the Declaration of Istanbul.
: Given the retrospective nature of this study, individual patient consent was waived and a summary of the study was publicly disclosed in an opt-out format.
